Welcome to our dedicated page for Calumet SEC filings (Ticker: CLMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles U.S. SEC filings for Calumet, Inc. (NASDAQ: CLMT), a petroleum refineries industry company that manufactures, formulates and markets specialty branded products and renewable fuels. Through these filings, investors can review Calumet’s regulatory disclosures on operations, financing activities, internal controls and segment performance across Specialty Products and Solutions, Montana/Renewables, Performance Brands and Corporate.
Current reports on Form 8-K are a central source of Calumet information. The company uses Item 2.02 filings to furnish results of operations and financial condition for specific quarters, referencing press releases that contain detailed financial data. These 8-Ks allow readers to see how Calumet reports quarterly performance, including metrics such as net income (loss) and non-GAAP measures like Adjusted EBITDA and Adjusted EBITDA with Tax Attributes, which the company explains in its disclosures.
Calumet has also filed 8-Ks under Item 4.02 describing non-reliance on previously issued financial statements. In one such filing, the Audit Committee concluded that unaudited interim consolidated financial statements for certain 2025 periods required restatement due to an error in the unaudited condensed consolidated statements of cash flows. The company explained that the error involved misclassification between operating and financing cash flows, did not affect revenue, net income (loss) or cash and cash equivalents, and was associated with a material weakness in internal control over financial reporting. The filing outlines planned restatements and discussions with the independent registered public accounting firm.
Other 8-K filings detail material definitive agreements and related transactions. For example, Calumet reported a sale and leaseback transaction for property comprising the Shreveport refinery fuels terminal, truck rack and related piping and equipment, documented under a Master Lease Agreement and property schedule with Stonebriar Commercial Finance LLC. The filing describes lease terms, rental payments, an option to repurchase the leased assets, application of proceeds to prior obligations, and related amendments to the company’s credit agreement and monetization master agreement.
Calumet’s filings also reference its capital structure, including various series of senior notes such as 11.00% Senior Notes due 2026, 8.125% Senior Notes due 2027, 9.75% Senior Notes due 2028 (including a mirror issuance), and 9.25% Senior Secured First Lien Notes due 2029. Definitions of "Consolidated Cash Flow" and "Consolidated EBITDA" used in these instruments are linked to the company’s non-GAAP measures, and the filings explain how these metrics are reported to noteholders and lenders.
On Stock Titan, Calumet’s SEC filings are updated from EDGAR and presented with AI-powered summaries. AI analysis highlights key terms in 10-K and 10-Q reports, explains complex sections such as non-GAAP reconciliations and covenant definitions, and surfaces important items from 8-Ks, including restatement notices, internal control disclosures and material transactions. Users can also review Form 4 and other ownership filings to track insider transactions, alongside proxy and other statements that address governance and compensation when available.
By combining real-time access to Calumet’s SEC submissions with AI-generated explanations, this page helps readers understand how the company reports its specialty products and renewable fuels operations, manages its capital structure and addresses financial reporting and control matters in its official filings.
Two Seas Capital LP, its general partner and Sina Toussi report beneficial ownership of 8,098,229 shares of Calumet, Inc. common stock, equal to 9.3% of the class as of December 31, 2025.
The position is held through Two Seas Global (Master) Fund LP and includes 6,976,229 shares plus options to purchase 1,122,000 additional shares. The reporting persons indicate sole voting and dispositive power over these shares. The 9.3% figure is based on 86,754,321 shares outstanding as of November 10, 2025. They certify the holdings are in the ordinary course of business and not for changing or influencing control of Calumet.
Calumet, Inc. has amended its main credit facility through a Ninth Amendment to its Third Amended and Restated Credit Agreement. The change extends the facility’s maturity to January 23, 2031 and sets total lender commitments at $500.0 million, subject to borrowing base limitations.
The amendment also revises covenants, representations, warranties and events of default so the company or its subsidiaries can complete new inventory financing transactions once certain customary conditions are met. If any such inventory financing transaction occurs, total commitments under the credit agreement will be reduced from $500.0 million to $425.0 million.
Calumet, Inc. reported that subsidiaries Calumet Specialty Products Partners, L.P. and Calumet Finance Corp. issued $405.0 million of new 9.75% Senior Notes due 2031 in a private Rule 144A/Reg S offering. The notes were sold at 98.996% of par, generating approximately $393.0 million in net proceeds after discounts and expenses.
The company plans to use these proceeds, along with cash on hand and borrowings under its revolving credit facility, to redeem all outstanding 11.00% Senior Notes due 2026 and 8.125% Senior Notes due 2027, with redemptions expected on or before January 21, 2026. The new notes mature on February 15, 2031, pay interest semi-annually, carry senior unsecured guarantees from the parent and most subsidiaries, and include customary covenants, change-of-control repurchase rights at 101%, and specified call premiums starting in 2028.
Calumet, Inc. reported that its affiliates Calumet Specialty Products Partners, L.P. and Calumet Finance Corp. agreed to sell $405.0 million of 9.75% Senior Notes due 2031 in a private offering under Rule 144A and Regulation S. The notes will be issued at 98.996% of par, providing approximately $393.0 million in net proceeds after discounts and estimated expenses, and are expected to close on January 12, 2026, subject to customary conditions.
The company plans to use the net proceeds, along with cash on hand and borrowings under its revolving credit facility, to redeem all outstanding 11.00% Senior Notes due 2026 and 8.125% Senior Notes due 2027 on or before January 21, 2026, thereby addressing these upcoming debt maturities.
Calumet, Inc. announced that its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. and Calumet Finance Corp., intend to offer $350.0 million in aggregate principal amount of senior unsecured notes due 2031 in a private placement to eligible purchasers. Calumet plans to use the net proceeds from the new notes, together with cash on hand and borrowings under its revolving credit facility, to redeem all of its outstanding 11.00% Senior Notes due 2026 on or around January 21, 2026 and $275.0 million of its outstanding 8.125% Senior Notes due 2027 on or around January 16, 2026. The notes will not be registered under the Securities Act or state securities laws and may only be offered and sold in the United States pursuant to an applicable registration exemption.
Calumet, Inc. filed a current report noting that it has issued a press release with preliminary, unaudited information about its liquidity and select fiscal year 2025 financial results. The press release is attached as an exhibit to the report and is incorporated by reference. The company also clarifies that this preliminary financial and liquidity information is being furnished rather than filed, so it is not automatically subject to certain Exchange Act liabilities or included in other securities filings unless specifically cited.
Calumet, Inc. reported that one of its directors acquired 5,053 shares of common stock, par value $0.01 per share, on 12/04/2025 through the settlement of restricted stock units at a price of $0 per share.
After this transaction, the director directly beneficially owned 24,733 shares of Calumet common stock. The related derivative position of 5,053 restricted stock units was reduced to zero as they were fully converted into common stock, with each unit economically equivalent to one share and 100% vested.
Calumet, Inc. reported an insider equity transaction by one of its directors.
On December 4, 2025, the director converted 2,526 restricted stock units into common stock and disposed of 1,011 common shares. After these transactions, the director beneficially owns 28,793 shares of Calumet common stock directly. Each restricted stock unit is the economic equivalent of one Calumet common share, is 100% vested, and can be settled in shares or their cash value. The director elected to have 40% of the vested restricted stock units settled in the cash equivalent of a common share.
Calumet (CLMT) reported a Form 4 for a director showing awards of restricted stock units on 11/06/2025. The filing lists 1,281 RSUs (Transaction Code A) at a price of $0 and 427 RSUs (Code A) at a price of $0, both recorded as direct ownership.
The 1,281 RSUs are 100% vested and settle upon the earlier of a specified date or the reporting person’s termination. The 427 RSUs settle under the Deferred Compensation Plan and vest 25% on July 1 of each year beginning July 1, 2026.
Calumet, Inc. (CLMT) reported a director’s equity award activity. On November 6, 2025, the reporting person acquired 384 Restricted Stock Units (RSUs) and 128 RSUs at $0 per unit, reported as direct ownership.
Each RSU equals one share of Calumet common stock. The 384 RSUs are 100% vested and will be settled upon the earlier of a date specified by the reporting person or the reporting person’s termination date. The 128 RSUs, granted under the Deferred Compensation Plan, will be settled upon the earlier of a specified date or termination, with 25% vesting each July 1 beginning July 1, 2026.